Novel Protein Glycan Side-Chain Biomarker and Risk of Incident Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objectives—: Enzymatically glycosylated proteins partake in multiple biological processes, including glucose transport and inflammation. We hypothesized that a novel biomarker (GlycA) of N -acetyl methyl groups originating mainly from N -acetylglucosamine moieties of acute-phase glycoproteins is related to incident type 2 diabetes mellitus and compared it with high-sensitivity C-reactive protein. Approach and Results—: In 26 508 initially healthy women free of diabetes mellitus, baseline GlycA and high-sensitivity C-reactive protein were quantified by nuclear magnetic resonance spectroscopy and immunoturbidimetry, respectively. During median follow-up of 17.2 years, 2087 type 2 diabetes mellitus cases occurred. In Cox models with adjustment for age, race, smoking, alcohol, activity, menopausal status, hormone use, family history, and body mass index, quartile 4 versus 1 hazard ratios and 95% confidence intervals were 2.67 (2.26–3.14) for GlycA and 3.93 (3.24–4.77) for high-sensitivity C-reactive protein; both P trend <0.0001. Associations for GlycA and high-sensitivity C-reactive protein were attenuated after additionally adjusting for lipids: 1.65 (1.39–1.95) and 2.83 (2.32–3.44), respectively, both P trend <0.0001, and after mutual adjustment: 1.11 (0.93–1.33; P trend=0.10) and 2.57 (2.09–3.16; P trend<0.0001), respectively. Conclusions—: Our finding of an association between a consensus glycan sequence common to a host of acute-phase reactants and incident type 2 diabetes mellitus provides further support for inflammation in the development of type 2 diabetes mellitus. Additional studies exploring the role of enzymatic glycosylation in the prevention of type 2 diabetes mellitus are warranted. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00000479.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Self-citationInterleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Salicylate (Salsalate) in Patients With Type 2 Diabetes: A Randomized Trial
Goldfine, A. B., Fonseca, V., Jablonski, K. A., Chen, Y.-D. I., Tipton, L., Staten, M. A., & Shoelson, S. E. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-1-201307020-00003 · Cited by 251
Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport
Ohtsubo, K., Chen, M. Z., Olefsky, J. M., & Marth, J. D. (2011) · Nature Medicine · doi:10.1038/nm.2414 · Cited by 249 · cited 1×
“In this regard, the functional integrity of proteins essential to glucose trafficking have been correlated with specific glycosylation patterns, as exemplified in experiments demonstrating that altered glycosylation patterns of insulin signal transduction proteins impair glucose homeostasis and β-islet cell function.(…”
BackgroundHak, A. E., Pols, H. A. P., Stehouwer, C. D. A., Meijer, J., Kiliaan, A. J., Hofman, A., Breteler, M. M. B., & Witteman, J. C. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7873 · Cited by 184
Cited by
Chambers, E. S., Byrne, C. S., Morrison, D. J., Murphy, K. G., Preston, T., Tedford, C., Garcia-Perez, I., Fountana, S., Serrano-Contreras, J. I., Holmes, E., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318424 · Cited by 443
Highlighting Diabetes Mellitus: The Epidemic Continues
Schmidt, A. M. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.310221 · Cited by 292
GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk
Connelly, M. A., Otvos, J. D., Shalaurova, I., Playford, M. P., & Mehta, N. N. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1321-6 · Cited by 281
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Wang, Q., Ferreira, D. L. S., Nelson, S. M., Sattar, N., Ala-Korpela, M., & Lawlor, D. A. (2018) · BMC Medicine · doi:10.1186/s12916-018-1008-8 · Cited by 134
Matricciani, L., Dumuid, D., Paquet, C., Fraysse, F., Wang, Y., Baur, L. A., Juonala, M., Ranganathan, S., Lycett, K., Kerr, J. A., et al. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2020.12.001 · Cited by 46
Metadata
- Authors
- Akinkuolie, A. O., Pradhan, A. D., Buring, J. E., Ridker, P. M., & Mora, S.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2015-06
- Volume
- 35
- Issue
- 6
- Pages
- 1544-1550
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2133346314
- Cited by
- 124
- References
- 5
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel Protein Glycan Side-Chain Biomarker and Risk of Incident Type 2 Diabetes Mellitus. https://app.cochat.ai/papers/10.1161/atvbaha.115.305635
- The paper
- Akinkuolie, A. O., Pradhan, A. D., Buring, J. E., Ridker, P. M., & Mora, S. (2015). Novel Protein Glycan Side-Chain Biomarker and Risk of Incident Type 2 Diabetes Mellitus. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.115.305635
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.